Norman L. Rosen
Mark A. Ramirez
Garrison Pease
Genitourinary/Urologic (prostate, kidney, bladder, testicle, penis, adrenal gland) Pathology, with focus on one-on-one teaching at the scope with residents and medical students, along with quality assurance and quality improvement mind-set with emphasis on lab efficiency and patient-centered turn-around time.<quillbot-extension-portal></quillbot-extension-portal>
Genitourinary/Urologic Pathology, Quality Assurance and Improvement<quillbot-extension-portal></quillbot-extension-portal>
<p>Garrison Pease, MD, is an attending surgical pathologist and Assistant Professor, Pathology at Montefiore Einstein. His clinical focus centers on genitourinary and urologic pathology, with a focus on one-on-one teaching at the scope with residents and medical students. He is also focused on quality assurance and quality improvement with an emphasis on lab efficiency and patient-centered turn-around time.</p><p>After obtaining his Bachelor of Arts in biology from Saint John's University (Collegeville, MN) in 2009, Dr. Pease earned his Doctor of Medicine at the University of Minnesota in 2013. He completed his anatomic and clinical pathology residency at the University of University of Chicago - NorthShore in 2017, where he was Chief Resident in his final two years. Following this, Dr. Pease completed a general surgical pathology fellowship at Washington University – St. Louis in 2018, followed by a genitourinary pathology fellowship at the University of Washington in 2019.</p><p>Dr. Pease’s research is focused on genitourinary and urologic pathology and quality assurance and improvement. He has worked on the College of American Pathologists (CAP) self and peer-based laboratory inspections. His work has been published in several peer-reviewed journals and shared through abstracts and poster presentations nationally and internationally.</p><p>Dr. Pease is a Diplomate of the American Board of Pathology and is board certified in Anatomic and Clinical Pathology. He is a member of the United States and Canadian Academy of Pathology and the College of American Pathologists. In 2021, Dr. Pease won the Department of Pathology Outstanding Teaching Award from Montefiore Einstein's Pathology Residency program.</p>
Sophia N. Palmer
<p>Minimally Invasive Gynecologic Surgery</p>
<p>Advanced Gynecologic Ultrasound</p>
<p>Individualized, Patient-Centered Care</p>
<p>Uterine Fibroids, Adenomyosis, Endometriosis, Abnormal Uterine Bleeding, Pelvic Pain, Myofascial Pain, Endometrial polyps, Abnormal PAP Smears, Cervical Dysplasia, Polycystic Ovarian Syndrome (PCOS), Infertiilty, Vulvar disorders.</p>
<p> </p>
<p><span style="text-decoration: underline;"><strong>Publications and Abstracts </strong></span></p>
<p><strong>Palmer S</strong>, Greenburg JA. Transcervical sterilization: A comparison of Essure permanent birth control system and Adiana permanent contraception system. Rev Obstet Gynecol. 2009 Spring;2(2):84-92.</p>
<p><strong>Palmer S</strong>, Chudnoff S, Levie M. Knowledge of Basic Electrosurgical Principles: A Survey of Surgeons Albert Einstein College of Medicine, Resident Research Day June 2008</p>
<p>AAGL 38th Global Congress of Minimally Invasive Gynecology Nov 2009 Levie M, Chudnoff S, <strong>Palmer S</strong>. Hysteroscopic Placement of Essure Device in an Office Setting: A Critical Analysis</p>
<p>AAGL 37th Global Congress of Minimally Invasive Gynecology Nov 2008 Blackwood A, Young M, Schuchter L , Guerry D, Dhulipala R , <strong>Palmer S</strong>, Ganguly A. Multiple Primary Melanoma, Family History, and Germline Mutations in CDKN2A. 1999 ASCO Annual Meeting</p>
Stuart Packer
<p>Stuart Packer, MD, is a medical oncologist with extensive experience in treating lung, head and neck, prostate and other types of cancer. After graduating magna cum laude from Case Western Reserve University, Dr. Packer received his medical degree from the State University of New York/Downstate Medical Center. He went on to complete a residency in medicine and fellowship in hematology/medical oncology at Duke University Medical Center. Since then Dr. Packer has held clinical and teaching positions at leading cancer centers, including Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and Montefiore Einstein Center for Cancer Care.</p>
<p>Dr. Packer’s clinical expertise is in medical management of lung cancer, head and neck cancer and prostate cancer. He is director of the melanoma and sarcoma programs at Montefiore Einstein Center for Cancer Care. In addition, Dr. Packer is medical director of Montefiore’s Oncology Care Model (OCM), an alternative payment model sponsored by the Centers for Medicare and Medicaid Services and aimed at improving patient care coordination and appropriateness of care.</p>
<p>Dr. Packer is the author or co-author of medical textbook chapter and articles in peer-reviewed journals, including <em>Cancer, Clinical Cancer Research, British Medical Journal</em> and <em>Lung Cancer</em>. He is a member of the American Society of Clinical Oncology and the American Society of Hematology.</p>
Dr. Packer’s clinical expertise is in medical management of lung cancer, head and neck cancer and prostate cancer.
<p>Stuart Packer, MD, is a medical oncologist with extensive experience in treating lung, head and neck, prostate and other types of cancer. After graduating magna cum laude from Case Western Reserve University, Dr. Packer received his medical degree from the State University of New York/Downstate Medical Center. He went on to complete a residency in medicine and fellowship in hematology/medical oncology at Duke University Medical Center. Since then Dr. Packer has held clinical and teaching positions at leading cancer centers, including Memorial Sloan-Kettering Cancer Center, Mount Sinai School of Medicine and Montefiore Einstein Center for Cancer Care.</p><p>Dr. Packer’s clinical expertise is in medical management of lung cancer, head and neck cancer and prostate cancer. He is director of the melanoma and sarcoma programs at Montefiore Einstein Center for Cancer Care. In addition, Dr. Packer is medical director of Montefiore's Oncology Care Model (OCM), an alternative payment model sponsored by the Centers for Medicare and Medicaid Services and aimed at improving patient care coordination and appropriateness of care.</p><p>Dr. Packer is the author or co-author of medical textbook chapter and articles in peer-reviewed journals, including <em>Cancer</em>, <em>Clinical Cancer Research</em>, <em>British Medical Journal</em> and <em>Lung Cancer</em>. He is a member of the American Society of Clinical Oncology and the American Society of Hematology.</p>
Maja H. Oktay
<p>Maja Oktay, MD/Ph.D., is a physician-scientist. She is a board-certified anatomical pathologist and cytopathologist with a Ph.D. and post-doctoral training in cancer cell biology and cell signaling pathways. Her major interests are in cancer cell biology, the biology of breast cancer progression and metastasis, the effect of chemotherapy and endocrine therapy on the tumor microenvironment, racial disparity in cancer, as well as development of prognostic and predictive molecular biomarkers. Her work is based on the analysis of the cancer microenvironment using mouse models of cancer, intravital multiphoton imaging, and digital pathology as well as minimally invasive procedures for diagnosis and prognosis of human malignancies, such as fine-needle aspiration (FNA) biopsy.</p>
<p>Dr. Oktay is a translational (bench to bedside) researcher in Einstein’s <a href="/research/integrated-imaging-program/">Integrated Imaging Program</a> where basic science findings are applied to clinical care through the integration and validation of high-resolution optical imaging with currently used clinical imaging methods.</p>
<p>Dr. Oktay established New York Pathology Oncology Group (NYPOG) and is the current director of NYPOG (https://einsteinmed.org/research/groups/ny-pathology-oncology/).</p>
<h3>Contribution to Science:</h3>
<p>Maja Oktay studies breast cancer microenvironments responsible for metastasis. In particular, the function of breast cancer intravasation sites called TMEM (Tumor MicroEnvironment of Metastasis) and its interactions with pro-metastatic Mena-expressing tumor cells and cancer stem cells. Using fine needle aspiration (FNA) biopsy obtained breast cancer cells from patients she determined that invasive cancer cells (MenaINV expressing) and cancer cells expressing stem cell markers correlate with TMEM score breast cancers from patients indicating mechanistic involvement of MenaINV, and stemness in TMEM function in human breast cancer. In addition, using FNA obtained cancer cells from patients for functional in vitro trans-endothelial migration studies she demonstrated that TMEM sites and MenaINV expression in cancer cells are essential for cancer cell trans-endothelial migration in all clinical subtypes of breast cancer. She also participated in the prospective validation study which demonstrated that TMEM score is a predictive marker of metastasis in breast cancer patients, as well as in the study which demonstrated that TMEM sites are functional sites of transient blood vessel permeability and as such the only sites of breast cancer cell intravasation. In addition, she led a study that established that commonly used chemotherapy for breast cancer can induce TMEM and MenaINV mediated pro-metastatic changes in breast cancer in the neoadjuvant setting and demonstrated that these changes can be reversed by Tie2 inhibition. More recently, Dr. Oktay co-led a study that elucidated the mechanism of induction of stem and invasive breast cancer cells. Using high-resolution intravital microscopy and a biosensor for cancer stem cells (CSC) the team also observed that CSCs display disseminating phenotype and using mouse and patient-derived breast cancers determined that tumor microenvironments, in particular around TMEM doorways, are sites of CSC induction.</p>
<p><strong>Mentoring:</strong></p>
<p><span style="font-size: 11.0pt; mso-bidi-font-size: 12.0pt; font-family: 'Arial',sans-serif; mso-fareast-font-family: 'Times New Roman'; mso-bidi-font-family: 'Times New Roman'; mso-ansi-language: EN-US; mso-fareast-language: EN-US; mso-bidi-language: AR-SA;">Throughout her career, Dr. Oktay served as a mentor to junior colleagues. She trained numerous individuals at various stages of their careers including high school students, MD/Ph.D. students, pathology residents, and cytopathology fellows, as well as post-doctoral fellows and junior faculty. During the past 10 years, she trained 5 pre- and 15 post-doctorates, all of whom have continued in research or research-related careers. Moreover, she has been mentoring T32 fellows since 2015, with 7 trainees in total. Most of the training interactions have resulted in publications or grant submissions and funded grants. </span></p>
<p class="MsoNormal" style="page-break-after: avoid; mso-outline-level: 1; margin: .25in 0in 6.0pt 0in;"> </p>
<p><a class="button expand-for-small-only" title="View Maja Oktay's bibliography" href="https://www.ncbi.nlm.nih.gov/myncbi/maja.oktay.1/bibliography/public/">… Bibliography</a></p>
<p style="font-variant-ligatures: normal; font-variant-caps: normal; orphans: 2; text-align: start; widows: 2; -webkit-text-stroke-width: 0px; text-decoration-thickness: initial; text-decoration-style: initial; text-decoration-color: initial; word-spacing: 0px;"><a href="https://www.ncbi.nlm.nih.gov/myncbi/maja.oktay.1/bibliography/public/">…;
<p class="DataField11pt-Single"> </p>
Sun Young Oh
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">The clinical focus is on medical oncology and the systemic treatment of breast cancer.</span>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Oh’s research follows her clinical focus and has been shared through publication in peer-reviewed journals.</span>
<p>Sun Young Oh, MD, is an Oncologist and Assistant Professor, Oncology and Medicine at Montefiore Einstein. Her clinical focus is on medical oncology and the systemic treatment of breast cancer.</p><p>In 2003, Dr. Oh completed her Doctor of Medicine at Ewha Womans University in Seoul, South Korea. She pursued postdoctoral training in the United States completing her internal medicine internship at Lutheran Medical Center in 2006, her internal medicine residency at Jacobi Medical Center/Albert Einstein College of Medicine in 2008 and her hematology and oncology fellowship at Tufts Medical Center/Tufts University School of Medicine in 2015.</p><p>Dr. Oh’s research follows her clinical focus and has been shared through publication in peer-reviewed journals.</p><p>Dr. Oh is board certified in internal medicine, medical oncology and hematology. She is a member of the American Society of Clinical Oncology</p>
Nicole S. Nevadunsky
<p>Comprehensive care of women with uterine, cervical, and vulvar cancers. Interests include minimally invasive and robotic techniques. </p>
<p>Dr. Nicole Nevadunsky conducts translational research that enables her to deliver the highest quality care for her patients. She specializes in the prevention and treatment of gynecologic cancers. Recent clinical studies have evaluated palliative care in improving quality of life in patients with high risk primary or recurrent gynecologic malignancies; and physical activity interventions for endometrial cancer survivors.</p>
Renee M. Moadel
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">Dr. Moadel has been with Montefiore since 2002, with a clinical focus on therapeutic radiopharmaceuticals in oncology and pediatric nuclear medicine, and a particular interest in the therapy of thyroid, liver, and prostate cancers.</span><quillbot-extension-portal></quillbot-extension-portal>
<span style="color:#4d4d4d;font-family:Arial, Helvetica, source-code-pro, Menlo, Monaco, Consolas, 'Courier New', monospace;font-size:16px;background-color:#ffffff;">In addition to sarcoma, pulmonary embolism, and infection imaging, Dr. Moadel’s research focuses on engineering-driven medicine and the use of Y-90 microsphere therapy (a minimally evasive procedure combining embolization and radiation) for treating liver cancers. Her research examines many topics, ranging from nuclear therapy of breast cancer to methods of body scanning.</span><quillbot-extension-portal></quillbot-extension-portal>
<p>Renee M. Moadel, MD, MSc, is an Attending Physician in the Department of Radiology and an Assistant Professor of Nuclear Medicine and Medicine at our Albert Einstein College of Medicine. Dr. Moadel has been with Montefiore since 2002, with a clinical focus on therapeutic radiopharmaceuticals in oncology and pediatric nuclear medicine, and a particular interest in the therapy of thyroid, liver, and prostate cancers.</p><p>Dr. Moadel received her Doctor of Medicine in 1996 and Master of Clinical Research in 2007 at our Albert Einstein College of Medicine. From 1996 to 2001, Dr. Moadel completed her postgraduate training with a residency in medicine and nuclear medicine, a chief residency in nuclear medicine, and a fellowship in nuclear medicine at our Albert Einstein College of Medicine.</p><p>In addition to sarcoma, pulmonary embolism, and infection imaging, Dr. Moadel’s research focuses on engineering-driven medicine and the use of Y-90 microsphere therapy (a minimally evasive procedure combining embolization and radiation) for treating liver cancers. Her research examines many topics, ranging from nuclear therapy of breast cancer to methods of body scanning. Dr. Moadel’s work has been published in a number of reviewed journals, books, and review articles.</p><p>In 1998, Dr. Moadel was the recipient of the Leo M. Davidoff Society Award for Teaching in Internal Medicine by Montefiore, which honors teachers who have made significant contributions to the education of students of our Albert Einstein College of Medicine.</p><p>She is board certified by the American College of Nuclear Medicine, sitting on the Board of Regents.</p>